Rare diseases
Investigational molecules
Locations
Study on Pembrolizumab for Patients with High-Risk Stage III Melanoma After Surgery
FranceStudy Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment
FranceStudy on Apixaban for Patients with Intrahepatic Non-Cirrhotic Portal Hypertension
FranceStudy on the Safety and Effectiveness of NMD670 for Adults with Charcot-Marie-Tooth Disease Types 1 and 2
FranceStudy Comparing Adagrasib and Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation
FranceStudy of ianalumab versus placebo in adults with warm autoimmune hemolytic anemia who failed previous treatment
FranceStudy on Durvalumab and Tremelimumab for Patients with Advanced Liver Cancer Not Treatable by Surgery
FranceStudy on Durvalumab, Tremelimumab, and Enfortumab Vedotin for Patients with Muscle Invasive Bladder Cancer Ineligible or Refusing Cisplatin
FranceStudy on the Safety of Tirbanibulin and Diclofenac Sodium for Adults with Actinic Keratosis on the Face or Scalp
FranceStudy on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma
FranceStudy of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer
FranceStudy on the Effectiveness and Safety of Ranibizumab for Patients with Wet Age-Related Macular Degeneration Using a 36-Week Refill System
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
